ATE99164T1 - Zahnbehandlung durch freisetzung von vesikeln. - Google Patents

Zahnbehandlung durch freisetzung von vesikeln.

Info

Publication number
ATE99164T1
ATE99164T1 AT88907972T AT88907972T ATE99164T1 AT E99164 T1 ATE99164 T1 AT E99164T1 AT 88907972 T AT88907972 T AT 88907972T AT 88907972 T AT88907972 T AT 88907972T AT E99164 T1 ATE99164 T1 AT E99164T1
Authority
AT
Austria
Prior art keywords
liposome
vesicles
release
dental treatment
hydroxyapatite
Prior art date
Application number
AT88907972T
Other languages
English (en)
Inventor
W Blair Geho
Joseph Jacob
John R Lau
Original Assignee
Technology Unlimited Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Unlimited Inc filed Critical Technology Unlimited Inc
Priority claimed from CA000575765A external-priority patent/CA1333359C/en
Application granted granted Critical
Publication of ATE99164T1 publication Critical patent/ATE99164T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT88907972T 1988-08-22 1988-08-22 Zahnbehandlung durch freisetzung von vesikeln. ATE99164T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1988/002776 WO1990001923A1 (en) 1988-08-22 1988-08-22 Dental therapy by vesicle delivery
CA000575765A CA1333359C (en) 1986-06-24 1988-08-26 Dental therapy by vesicle delivery

Publications (1)

Publication Number Publication Date
ATE99164T1 true ATE99164T1 (de) 1994-01-15

Family

ID=4138623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88907972T ATE99164T1 (de) 1988-08-22 1988-08-22 Zahnbehandlung durch freisetzung von vesikeln.

Country Status (4)

Country Link
EP (1) EP0429442B1 (de)
AT (1) ATE99164T1 (de)
DE (1) DE3886775T2 (de)
WO (1) WO1990001923A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0479582A1 (de) * 1990-10-03 1992-04-08 Alexander Karl Friedrich Wilhelm Overweg Periodentium regenerierende Technik
US6416745B1 (en) * 2001-05-03 2002-07-09 Block Drug Company, Inc. Dental composition for treating hypersensitive teeth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377567A (en) 1978-10-02 1983-03-22 The Procter & Gamble Company Lipid membrane drug delivery
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
US4767615A (en) * 1984-05-03 1988-08-30 Technology Unlimited, Inc. Dental therapy by vesicle delivery

Also Published As

Publication number Publication date
DE3886775D1 (de) 1994-02-10
DE3886775T2 (de) 1994-04-14
EP0429442A1 (de) 1991-06-05
EP0429442B1 (de) 1993-12-29
EP0429442A4 (en) 1991-07-03
WO1990001923A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
DE59006880D1 (de) Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin.
DE3783394D1 (de) Arzneizubereitung zur oralen anwendung.
DE68928956D1 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butanediol
ATE77051T1 (de) Liposom-zusammensetzung.
DE3680368D1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
FI102591B (fi) Pursotettava, joustava, suun kautta annettava liuoksen muodossa oleva geelikoostumus käytettäväksi terapeuttisten aineiden kantajana
ATE82118T1 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
ATE77229T1 (de) Verwendung eines dentalwerkstoffs zur bekaempfung von karies und parodontose.
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
ATE99164T1 (de) Zahnbehandlung durch freisetzung von vesikeln.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
ES8708241A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE68914175D1 (de) Parfümgrundzusammenstellung enthaltendes 2-cyclohexylpropanal und Verfahren zur Herstellung dieser Verbindung.
ATE104847T1 (de) Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.
IT210095Z2 (it) Poltrona odontoiatrica per paziente conimbottitura asportabile.
IT8920158A0 (it) Nuovo procedimento per la preparazione in vitro di membrane emostatiche artificiali.
FR2638961B1 (fr) Plateau dentaire pour la realisation, notamment, de dents artificielles en porcelaine ou analogue
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee